CSIMarket Company Name, Ticker, Competitors, else..
 
Kyverna Therapeutics Inc   (NASDAQ: KYTX)
Other Ticker:  
 
 

Kyverna Therapeutics Inc's Customers Performance

KYTX


 
 
KYTX's Source of Revenues

• List of KYTX Customers




for the same period Kyverna Therapeutics Inc

• List of KYTX Customers





Kyverna Therapeutics Inc's Comment on Sales, Marketing and Customers





  News about Kyverna Therapeutics Inc Contracts

Class Action Looms Over Kyverna Therapeutics, Inc. with February Deadline for Lead Plaintiffs

In a significant development for stakeholders of Kyverna Therapeutics, Inc. investors are being alerted to an impending class action lawsuit against the company. Levi and Korsinsky, LLP, a prominent securities litigation firm, has issued a notice to investors regarding the class action lawsuit, urging them to be aware of a critical deadline. The legal proceedings come with a lead plaintiff deadline set for February 7, 2025. Kyverna Therapeutics, Inc. publicly traded on the NASDAQ under the ticker symbol KYTX, has found itself at the center of this legal matter amidst challenging market conditions. As of the writing of this article, the company s stock price stands at a mere $3.99, reflecting broader concerns...

Kyverna Therapeutics Investors Advised to Seek Counsel Ahead of Securities Class Action Deadline

In a recent development significant to investors in the biotechnology sector, Rosen Law Firm, a prominent global investor rights law firm, has issued a reminder to those who purchased common stock of Kyverna Therapeutics, Inc. (NASDAQ: KYTX). The firm emphasizes that these investors, whose stock purchases are pursuant and/or traceable to the company?s initial public offering conducted on February 8, 2024, are approaching an important legal deadline.Kyverna Therapeutics, Inc. known for its innovations in the field of cellular immunotherapy, became a publicly traded entity in early 2024, with an initial issuance of shares through its IPO. As of the current market assessment, the company has 43.16 million share...












KYTX's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Kyverna Therapeutics Inc 132.67 0.00 -145.42 -
SUBTOTAL 0.00 0.00 0.00 -


Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com